|
31.10.2024 11:50:35
|
Regeneron Pharmaceuticals Q3 Profit Increases, Beats Estimates
(RTTNews) - Regeneron Pharmaceuticals (REGN) revealed a profit for its third quarter that increased from the same period last year and beat the Street estimates.
The company's bottom line came in at $1.341 billion, or $11.54 per share. This compares with $1.008 billion, or $8.89 per share, in last year's third quarter.
Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $1.462 billion or $12.46 per share for the period.
Analysts on average had expected the company to earn $11.69 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 10.6% to $3.721 billion from $3.363 billion last year.
Regeneron Pharmaceuticals earnings at a glance (GAAP) :
-Earnings (Q3): $1.341 Bln. vs. $1.008 Bln. last year. -EPS (Q3): $11.54 vs. $8.89 last year. -Revenue (Q3): $3.721 Bln vs. $3.363 Bln last year.
Nachrichten zu Regeneron Pharmaceuticals Inc.
Analysen zu Regeneron Pharmaceuticals Inc.
3 Knaller-Aktien im BX Musterportfolio📈: Fiserv Inc., Cintas & Blackstone mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Fiserv Inc.
✅ Cintas
✅ Blackstone
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| Regeneron Pharmaceuticals Inc. | 721.18 | -24.11% |
|
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
SMI stabil -- DAX sinkt leicht -- Asiens Börsen mehrheitlich höherDer heimische Markt zeigt sich zur Wochenmitte wenig verändert. Der deutsche Leitindex präsentiert sich derweil moderat im Minus. An den Märkten in Fernost geht es am Mittwoch mehrheitlich nach oben.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |